BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:University of Cambridge NIHR Blood  and Transplant Research Unit S
 eminar series  - Professor Pierre Tiberghien\,Université de Franche-Comt
 é and the European Blood Alliance
DTSTART:20230606T120000Z
DTEND:20230606T130000Z
UID:TALK201586@talks.cam.ac.uk
CONTACT:Anne Forde
DESCRIPTION:COVID-19 convalescent plasma to meet unmet therapeutic needs\n
 \nEarly transfusion of plasma donated by individuals having recovered from
  COVID-19 (COVID-19 convalescent plasma) is likely to reduce the risk of s
 evere COVID-19 lung inflammation. A correlation between the dose of neutra
 lising anti-SARS-CoV-2 antibodies in the transfused plasma and therapeutic
  success has been reported in several studies\, including those involving 
 hospitalised patients.\n\nThe evolution of the COVID-19 pandemic may inclu
 de the emergence of COVID-19 variants even less sensitive to the protectiv
 e vaccination and/or prior infection. In this setting\, high concentration
  plasma collected from donors recovering from these variants is likely to 
 constitute a treatment available quickly\, widely and inexpensively.\n\nIn
  this talk\, Pierre Tiberghien will discuss the French study CORIPLASM and
  other studies which suggest that CCP may be an effective therapeutic opti
 on in patients with underlying immunodeficiency and hospitalised with seve
 re COVID-19.\n\nThis event is hybrid.\nHeart and Lung Research Institute\,
  Biomedical Campus\, Papworth Road\, Trumpington\, Cambridge CB2 0BB – R
 oom - R101 (ground floor). Please email: af373@medschl.cam.ac.uk for onlin
 e link)\n
LOCATION:Victor Phillip Dahdaleh Heart and Lung Research Institute\,  Biom
 edical Campus\, Papworth Road\, Trumpington\, Cambridge CB2 0BB –
END:VEVENT
END:VCALENDAR